AnalystsRudy Li
Rudy Li's Stock Forecasts

Analyst Ranking
Top 3%
#107 out of 5220 analysts
Average Return
+81.92%
Win Rate
71%27 out of 38
Risk vs Reward
Poor
Good

Rudy Li's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Praxis Precision Medicines IncPRAX
+658.18%$38.09$288.79
2025-05-06 -
2026-03-18
Strong Buy
Alto Neuroscience IncANRO
+461.60%$4.01$22.52
2025-09-28 -
2026-03-18
Strong Buy
Praxis Precision Medicines IncPRAX
+416.07%$55.96$288.79
2025-07-28 -
2026-03-18
Strong Buy
Stoke Therapeutics IncSTOK
+275.54%$8.26$31.02
2025-03-18 -
2026-03-18
Strong Buy
Stoke Therapeutics IncSTOK
+233.12%$9.30$30.98
2025-02-18 -
2026-02-18
Strong Buy

Rudy Li's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Centessa Pharmaceuticals PLCCNTA
5Buy$40.00+39.32%Initiates Coverage On
24 days ago
Alkermes PLCALKS
1Buy$45.00+65.44%Initiates Coverage On
24 days ago
Axsome Therapeutics IncAXSM
1Buy$230.00+45.69%Initiates Coverage On
24 days ago
Xenon Pharmaceuticals IncXENE
5Buy$60.00+8.95%Initiates Coverage On
24 days ago
Stoke Therapeutics IncSTOK
5Buy$40.00+28.95%Initiates Coverage On
24 days ago
Praxis Precision Medicines IncPRAX
4Buy$500.00+73.14%Initiates Coverage On
24 days ago
Neurocrine Biosciences IncNBIX
1Buy$160.00+22.41%Initiates Coverage On
24 days ago
Definium Therapeutics IncDFTX
5Buy$25.00+41.72%Initiates Coverage On
24 days ago
Acadia Pharmaceuticals IncACAD
1Buy$33.00+62.40%Initiates Coverage On
24 days ago
Bright Minds Biosciences IncDRUG
3Strong Buy$80.00N/AMaintains
3 months ago
Immunic IncIMUX
1Strong Buy$3.00+160.87%Initiates Coverage On
6 months ago
Alto Neuroscience IncANRO
1Strong Buy$15.00-33.39%Initiates Coverage On
6 months ago
Reviva Pharmaceuticals Holdings IncRVPH
1Strong Buy$40.00+2,039.04%Initiates Coverage On
6 months ago
Prothena Corp Public Ltd CoPRTA
7Strong Buy$18.00+109.55%Maintains
7 months ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.